News

Seeking Alpha2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - Seeking Alpha
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in ...
Yahoo Finance2y
Bone Graft and Substitutes Market will reach to USD 5.78 billion by 2030 : GreyViews - Yahoo Finance
Bone Graft and Substitutes Market Size By Type (Allograft, Synthetic, Demineralized Bone Matrix (DMI), and Xenograft), By Application (Dental, Foot and Ankle, Long Bone, Craniomaxillofacial, Joint ...
PharmiWeb3y
Injectable Bone Graft Substitutes Market How Business will grow at 2031? Prominent Players: DePuy Synthes, Medtronic PLC, Nuvasive, Inc.
Injectable Bone Graft Substitutes Market research Report is an inestimable supply of insightful data for business strategists. This Injectable Bone Graft Substitutes Market study provides extensive ...
Business Wire5y
Global Bone Graft and Substitutes Market to Surpass US$ 4,673.5 Million by 2027 – Coherent Market Insights - Business Wire
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global bone graft and substitutes market is estimated to be valued at US$ 3,046.7 million in 2019, and is expected to exhibit a ...
Business Insider5y
Orthobiologics Market for Bone Repair & Regeneration,4 - Dominated by Medtronic, MTF Biologics, NuVasive, and Orthofix
DUBLIN, April 15, 2020 /PRNewswire/ -- The 'Orthobiologics for Bone Repair and Regeneration' report has been added to ResearchAndMarkets.com's off ...
Reuters18y
NuVasive buys bone grafting tech from Radius Medical | Reuters
Medical device company NuVasive Inc. <NUVA.O> said it acquired bone grafting technology from privately held, California-based Radius Medical LLC for about $16 million in cash and stock.
WKRN-TV2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - WKRN News 2
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...
KELOLAND News2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - KELOLAND.com
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...
KHON22y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...
WWLP-22News2y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - WWLP
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...
WPRI 122y
Clinical Study Validates NuVasive Porous Interbody Implant and Synthetic Bone Graft Substitute as Cost-effective Solution for Lateral Lumbar Interbody Fusions - WPRI.com
Spine surgeons validated clinical and economic benefits of an entirely synthetic solution in lateral lumbar fusions SAN DIEGO, July 26, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the ...